Medicare Enrolled
Dr. Andrew Muskovitz, M.D.
Hematology & Oncology · Southfield, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Muskovitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Muskovitz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Muskovitz
Dr. Andrew Muskovitz is a hematology & oncology specialist in Southfield, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Muskovitz performed 109,003 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Muskovitz received a total of $44,842 from 60 pharmaceutical and/or device companies across 351 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Muskovitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 5% volume in MI
$44,842 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗109,003
Medicare services
Top 5% in MI for hematology & oncology
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
54,060 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 19,200 | $36 | $63 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
8,500 | $0 | $0 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
4,800 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 4,620 | $19 | $25 |
| Paclitaxel chemotherapy injection | 3,330 | $0 | $2 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
2,330 | $6 | $15 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
2,310 | $22 | $100 |
| Injection, granisetron hydrochloride, 100 mcg | 1,350 | $0 | $5 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,230 | $0 | $2 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
753 | $8 | $10 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
700 | $8 | $25 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
576 | $75 | $342 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
554 | $98 | $175 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
464 | $12 | $50 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
352 | $100 | $300 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
349 | $2 | $10 |
| Anti-nausea injection (Aloxi/palonosetron) | 330 | $1 | $5 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
311 | $96 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
262 | $11 | $40 |
| Injection, leucovorin calcium, per 50 mg | 244 | $3 | $10 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
207 | $67 | $125 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
178 | $2 | $10 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
156 | $134 | $275 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
144 | $22 | $75 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
138 | $9 | $35 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
135 | $50 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
134 | $140 | $225 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
117 | $57 | $150 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
116 | $50 | $125 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
112 | $62 | $100 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
94 | $1 | $2 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
88 | $23 | $65 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
85 | $1 | $10 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
82 | $1 | $5 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
77 | $22 | $100 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
69 | $6 | $25 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
68 | $2 | $5 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
66 | $10 | $50 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
42 | $44 | $125 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
41 | $21 | $50 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
39 | $15 | $50 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
32 | $123 | $450 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
30 | $27 | $75 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $129 | $250 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
23 | $15 | $45 |
| New patient office visit, complex (60-74 min) | 22 | $164 | $305 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $101 | $200 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
18 | $93 | $200 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
17 | $20 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
50.4% high complexity
46.5% medium
3.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$44,842
Total received (2018-2024)
Avg $6,406/year across 7 years
Top 6% in MI for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
351
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$104
2023
$3,236
2022
$2,242
2021
$1,493
2020
$6,785
2019
$30,350
2018
$632
Payments by company (2024)
ABBVIE INC.
$79
JAZZ PHARMACEUTICALS INC.
$25
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Puma Biotechnology, Inc.
$31,440
Genentech USA, Inc.
$3,152
AbbVie Inc.
$2,710
Daiichi Sankyo Inc.
$974
ABBVIE INC.
$922
Amgen Inc.
$876
Novartis Pharmaceuticals Corporation
$639
NOVARTIS PHARMACEUTICALS CORPORATION
$283
GENZYME CORPORATION
$257
Janssen Biotech, Inc.
$215
PFIZER INC.
$168
Astellas Pharma US Inc
$161
AstraZeneca Pharmaceuticals LP
$144
Takeda Pharmaceuticals U.S.A., Inc.
$144
Incyte Corporation
$133
Focal Therapeutics, Inc.
$129
E.R. Squibb & Sons, L.L.C.
$128
JAZZ PHARMACEUTICALS INC.
$127
EMD Serono, Inc.
$126
Janssen Pharmaceuticals, Inc
$124
Gilead Sciences, Inc.
$121
SANOFI-AVENTIS U.S. LLC
$114
Seagen Inc.
$108
BeiGene USA, Inc.
$108
Merck Sharp & Dohme LLC
$91
GlaxoSmithKline, LLC.
$90
Exelixis Inc.
$89
Mirati Therapeutics, Inc.
$84
Sumitomo Pharma America, Inc.
$79
Bayer Healthcare Pharmaceuticals Inc.
$76
Lilly USA, LLC
$75
Eisai Inc.
$64
SOBI, INC
$63
Kite Pharma, Inc.
$61
SERVIER PHARMACEUTICALS LLC
$60
G1 Therapeutics, Inc.
$57
Genmab U.S., Inc.
$54
Ipsen Biopharmaceuticals, Inc
$51
Pharmacyclics LLC, An AbbVie Company
$42
Celgene Corporation
$39
Alnylam Pharmaceuticals Inc.
$38
Bayer HealthCare Pharmaceuticals Inc.
$34
TerSera Therapeutics LLC
$32
ARRAY BIOPHARMA INC
$30
Kyowa Kirin, Inc.
$29
AMAG Pharmaceuticals, Inc.
$27
TAIHO ONCOLOGY, INC.
$25
PharmaEssentia USA Corporation
$25
Jazz Pharmaceuticals Inc.
$24
Blueprint Medicines Corporation
$23
EISAI INC.
$22
Pharmacosmos Therapeutics Inc.
$21
Apellis Pharmaceuticals, Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$18
EUSA Pharma (US) LLC
$18
Deciphera Pharmaceuticals Inc.
$17
Stemline Therapeutics Inc.
$17
Karyopharm Therapeutics Inc.
$16
MorphoSys, US Inc.
$15
Octapharma USA, Inc.
$15
Top 3 companies account for 83.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · Alecensa · BAVENCIO · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · BioZorb · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CUVITRU · CYRAMZA · Cabometyx · Columvi · DARZALEX · Doptelet · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FARESTON · FERAHEME · GAZYVA · GIVLAARI · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · INVOKANA · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MVASI · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPDIVO · ORGOVYX · Oncaspar · Onivyde · Orserdu · PADCEV · PANHEMATIN · PEMAZYRE · PIQRAY · PROMACTA · Padcev · Perjeta · QINLOCK · REBLOZYL · SARCLISA · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · SPRYCEL · Stivarga · Sylvant · TAGRISSO · TASIGNA · TECENTRIQ · TEPMETKO · TIBSOVO · Tecentriq · Tibsovo · Trodelvy · VENCLEXTA · VERZENIO · VPRIV · VYXEOS · Vectibix · Venclexta · XALKORI · XPOVIO · XTANDI · Xermelo · Xospata · Yescarta · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
121
County median income
$95,296
Nearest hospital to ZIP centroid (approximate)
ASCENSION PROVIDENCE HOSPITAL, SOUTHFIELD AND NOVI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Muskovitz is a mixed practice specialist, with above-average Medicare volume (top 5% in MI), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Muskovitz experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Muskovitz performed 54,060 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Muskovitz receive payments from pharmaceutical companies?
Yes. Dr. Muskovitz received a total of $44,842 from 60 companies across 351 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Muskovitz's costs compare to other hematology & oncology specialists in Southfield?
Dr. Muskovitz's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Muskovitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Southfield
Browse hematology & oncology specialists in Southfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in MI
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in MI
Which MI hematology & oncology specialists receive the most from drug and device companies.
By company
Puma Biotechnology, Inc. Payments to Doctors
See all physicians who received payments from Puma Biotechnology, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology